References
- Conway O’Brien E, Prideaux S, Chevassut T. The epigenetic landscape of acute myeloid leukemia. Adv Hematol 2014;2014:103175.
- Rowe JM, Tallman MS. How I treat acute myeloid leukemia. Blood 2010;116:3147–3156.
- Platanias LC. Biological responses to arsenic compounds. J Biol Chem 2009;284:18583–18587.
- Breccia M, Cicconi L, Lo-Coco F. ATRA + ATO: has a new standard of care been established in low-risk acute promyelocytic leukaemia? Curr Opin Hematol 2014;21:95–101.
- Miller WH, Jr, Schipper HM, Lee JS, et al. Mechanisms of action of arsenic trioxide. Cancer Res 2002;62:3893–3903.
- Takahashi S. Combination therapy with arsenic trioxide for hematological malignancies. Anti-Cancer Agents Med Chem 2010; 10:504–510.
- Warrell RP, Jr. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers. Drugs Under Exp Clin Res 1986;12:275–282.
- Bennett DC, Charest J, Sebolt K, et al. High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer. Transl Oncol 2013;6:382–391.
- Nyoung MN, Trentesaux C, Aries A, et al. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Anticancer Res 1994;14:1203–1208.
- Song LX, Xu L, Li X, et al. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia. Ann Hematol 2012;91:1879–1886.
- Ye Y, Xu X, Zhang M, et al. Low-dose Arsenic trioxide combined with aclacinomycin A synergistically enhance the cytotoxic effect on human acute myelogenous leukemia cell line by induction of apoptosis. Leuk lymphoma 2015;56:3162–3170.
- Sato S, Sakashita A, Ishiyama T, et al. Possible differentiation treatment with aclacinomycin A in acute myelomonocytic leukemia refractory to conventional chemotherapy. Anticancer Res 1992;12: 371–376.
- Hu XM, Yuan B, Tanaka S, et al. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines. Hematology 2014;19:352–360.